Results 1 to 10 of about 163,967 (239)
Neuroendocrine tumors in the brain [PDF]
Annals of Oncology, 2001 Somatostatin and other neuropeptides are expressed in tumors originating from neuronal precursors and paraganglia, namely medulloblastoma, central Primitive Neuro-Ectodermal Tumors (cPNETs), neurocytoma, gangliocytoma. olfactory neuroblastoma, paraganglioma.
Paola Cavalla, D. Schiffer
openalex +3 more sources
Journal of the National Comprehensive Cancer Network, 2012 Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in the gastrointestinal tract, urogenital tract, endocrine, and bronchopulmonary system. NETs account for approximately 2.2% of all malignancies. These slow growing tumors are difficult to localize and often metastatic at diagnosis. Surgery can be curative
Bodei L +3 more
+9 more sources
Chemotherapy in Neuroendocrine Tumors [PDF]
Cancers, 2021 The role for cytotoxic chemotherapy in patients with well-differentiated neuroendocrine tumors (NETs) remains debated. Compared to patients with poorly differentiated neuroendocrine carcinomas (NECs) where chemotherapy is utilized ubiquitously, chemotherapy may play a more select role in patients with certain types of NETs (e.g., pancreatic tumors ...
Satya Das +2 more
openaire +3 more sources
Does epidural analgesia modify the risk of complications after gastrectomy?
Nowotwory, 2021 INTRODUCTION: The surgical treatment of Gastric Cancer is associated with overall complication rates as high as 50%. The intent of this study was to assess the impact of epidural analgesia (EA) on postoperative complication rates among patients ...
Tomasz Olesiński +6 more
doaj +1 more source
Nowotwory, 2023 INTRODUCTION: The purpose of this study is to evaluate the effect of esophagogastric junction cancer (EGJC) staging on the risk of splenic hilar lymph node involvement. MATERIAL AND METHODS: 312 patients with EGJC after R0 surgery were analyzed; 118 (38%)
Tomasz Olesiński +4 more
doaj +1 more source
Biomedicines, 2023 Angiogenic factors (AF) promote vascular formation and may thus support neuroendocrine tumour (NET) development. This study aimed to assess AF serum level changes in NET patients treated with prolonged-acting somatostatin analogues (SSAs).
Violetta Rosiek +2 more
doaj +1 more source
Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. [PDF]
, 2012 Pancreatic neuroendocrine tumors (PNETs) are relatively rare tumors that arise in the endocrine cells of the pancreas. Historically, somatostatin analogues have been used in this disease primarily for symptom control and, to a limited extent, disease ...
Devata, Sumana, Kim, Edward J
core +10 more sources
Biomedicines, 2023 The coronavirus disease-19 (COVID-19) pandemic dramatically impacted oncological patients’ care. Since the introduction of vaccines and the demonstration of their benefit on frail patients, COVID-19 vaccinations were indicated to also be beneficial to ...
Alice Laffi +12 more
doaj +1 more source
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”
Cancer Treatment and Research Communications, 2022 Background: Bone metastases (BM) are related to worse outcome in patients with neuroendocrine neoplasms (NENpts). Aim: Assess utility of serum tumor markers (STM) for detection of BM in lung NENpts.
Violetta Rosiek +2 more
doaj +1 more source
Neuroendocrine Tumors of the Thymus [PDF]
Thoracic Surgery Clinics, 2011 Neuroendocrine tumors of the thymus (NETTs) are unusual thymic neoplasms that were misdiagnosed as thymomas until the 1970s, when they eventually acquired a distinct identity. No collective large series have been published so far, and information about clinical presentation, diagnosis, histology, and treatment is derived from analysis of the case ...
RUFFINI, Enrico +4 more
openaire +3 more sources